These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 23445729

  • 1. [Biomarkers associated with unresponsiveness to IVIG in children with Kawasaki disease].
    Abe J, Matsuda A.
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(1):27-34. PubMed ID: 23445729
    [Abstract] [Full Text] [Related]

  • 2. Anti-inflammatory effects of high-dose IgG on TNF-α-activated human coronary artery endothelial cells.
    Matsuda A, Morita H, Unno H, Saito H, Matsumoto K, Hirao Y, Munechika K, Abe J.
    Eur J Immunol; 2012 Aug; 42(8):2121-31. PubMed ID: 22585560
    [Abstract] [Full Text] [Related]

  • 3. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease.
    Abe J, Ebata R, Jibiki T, Yasukawa K, Saito H, Terai M.
    J Allergy Clin Immunol; 2008 Nov; 122(5):1008-1013.e8. PubMed ID: 18930517
    [Abstract] [Full Text] [Related]

  • 4. Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease.
    Inoue T, Murakami S, Matsumoto K, Matsuda A.
    Pediatr Rheumatol Online J; 2020 Oct 06; 18(1):76. PubMed ID: 33023630
    [Abstract] [Full Text] [Related]

  • 5. Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance.
    Fury W, Tremoulet AH, Watson VE, Best BM, Shimizu C, Hamilton J, Kanegaye JT, Wei Y, Kao C, Mellis S, Lin C, Burns JC.
    Hum Immunol; 2010 Sep 06; 71(9):865-73. PubMed ID: 20600450
    [Abstract] [Full Text] [Related]

  • 6. Increase expression of CD177 in Kawasaki disease.
    Huang YH, Lo MH, Cai XY, Liu SF, Kuo HC.
    Pediatr Rheumatol Online J; 2019 Apr 03; 17(1):13. PubMed ID: 30943984
    [Abstract] [Full Text] [Related]

  • 7. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
    Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, Xu Y, Wu YF, Xia X, Wei W, Hu B.
    Clin Chim Acta; 2017 Aug 03; 471():76-80. PubMed ID: 28526535
    [Abstract] [Full Text] [Related]

  • 8. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
    Amano Y, Akazawa Y, Yasuda J, Yoshino K, Kojima K, Kobayashi N, Matsuzaki S, Nagasaki M, Kawai Y, Minegishi N, Ishida N, Motoki N, Hachiya A, Nakazawa Y, Yamamoto M, Koike K, Takeshita T.
    Pediatr Rheumatol Online J; 2019 Jul 03; 17(1):34. PubMed ID: 31269967
    [Abstract] [Full Text] [Related]

  • 9. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
    Ge X, Li CR, Yang J, Wang GB.
    Scand J Immunol; 2013 May 03; 77(5):389-97. PubMed ID: 23298273
    [Abstract] [Full Text] [Related]

  • 10. Transcriptional regulation by infliximab therapy in Kawasaki disease patients with immunoglobulin resistance.
    Ogihara Y, Ogata S, Nomoto K, Ebato T, Sato K, Kokubo K, Kobayashi H, Ishii M.
    Pediatr Res; 2014 Sep 03; 76(3):287-93. PubMed ID: 24964229
    [Abstract] [Full Text] [Related]

  • 11. Serum levels of neutrophil activation cytokines in Kawasaki disease.
    Suzuki H, Noda E, Miyawaki M, Takeuchi T, Uemura S, Koike M.
    Pediatr Int; 2001 Apr 03; 43(2):115-9. PubMed ID: 11285059
    [Abstract] [Full Text] [Related]

  • 12. Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease.
    Zhang RL, Lo HH, Lei C, Ip N, Chen J, Law BY.
    Curr Opin Pharmacol; 2020 Oct 03; 54():72-81. PubMed ID: 32956895
    [Abstract] [Full Text] [Related]

  • 13. Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease.
    Huang FC, Kuo HC, Huang YH, Yu HR, Li SC, Kuo HC.
    BMC Pharmacol Toxicol; 2017 Jan 09; 18(1):3. PubMed ID: 28069066
    [Abstract] [Full Text] [Related]

  • 14. Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange.
    Fujimaru T, Ito S, Masuda H, Oana S, Kamei K, Ishiguro A, Kato H, Abe J.
    Cytokine; 2014 Dec 09; 70(2):156-60. PubMed ID: 25082649
    [Abstract] [Full Text] [Related]

  • 15. Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.
    Armaroli G, Verweyen E, Pretzer C, Kessel K, Hirono K, Ichida F, Okabe M, Cabral DA, Foell D, Brown KL, Kessel C.
    Arthritis Rheumatol; 2019 May 09; 71(5):792-804. PubMed ID: 30447136
    [Abstract] [Full Text] [Related]

  • 16. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
    Int J Rheum Dis; 2013 Apr 09; 16(2):168-72. PubMed ID: 23773640
    [Abstract] [Full Text] [Related]

  • 17. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
    Chang LS, Lo MH, Li SC, Yang MY, Hsieh KS, Kuo HC.
    Oncotarget; 2017 Jan 10; 8(2):2044-2052. PubMed ID: 27893416
    [Abstract] [Full Text] [Related]

  • 18. Identifying genetic hypomethylation and upregulation of Toll-like receptors in Kawasaki disease.
    Huang YH, Li SC, Huang LH, Chen PC, Lin YY, Lin CC, Kuo HC.
    Oncotarget; 2017 Feb 14; 8(7):11249-11258. PubMed ID: 28061462
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
    Arthritis Rheum; 2013 Mar 14; 65(3):805-14. PubMed ID: 23440694
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of TLR2, 3, 9 and Signaling Mediators, MyD88 and TRIF, Gene Transcript Levels in Patients with Kawasaki Disease Treated with IVIG.
    Mortazavi SH, Amin R, Alyasin S, Kashef S, Karimi MH, Babaei M, Younesi V.
    Iran J Allergy Asthma Immunol; 2015 Apr 14; 14(2):188-97. PubMed ID: 25780885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.